Twin Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Twin Capital Management's WST Position: Q3 2026 in Review
Twin Capital Management reduced its West Pharmaceutical (WST) stake by 0.29% in Q3 2026, selling an estimated $8.83K and leaving 8,495 shares worth $3.15M. The position accounts for 0.33% of the portfolio, ranked #64.
Twin Capital Management first reported a position in WST in Q3 2018 and has held it in 17 quarters since. The position peaked at $7.76M in Q4 2021. 875 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Twin Capital Management held 8,495 shares of West Pharmaceutical worth $3.15M as of Q3 2026.
- Twin Capital Management sold 25 West Pharmaceutical shares in Q3 2026, an estimated $8.83K.
- West Pharmaceutical made up 0.33% of Twin Capital Management's portfolio in Q3 2026, its #64 holding.
- Twin Capital Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 17 quarters since.
- Twin Capital Management's West Pharmaceutical position peaked at $7.76M in Q4 2021.
- 875 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Twin Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.